Applied Therapeutics, Inc. (APLT) Covered Calls
There are no covered calls available for Applied Therapeutics, Inc..
Born To Sell's covered call screener gives you full search capabilities so you can find stocks and ETFs that make good covered call candidates.
Want to make money with covered calls? Sign Up For A Free Trial
Extended Business Description
Applied Therapeutics, Inc., a biopharmaceutical company, develops novel products to target cardiovascular disease, galactosemia, and diabetic complications. Its lead product candidate is AT-007 that is in phase I/II for the treatment of galactosemia; AT-001 that is in phase II clinical trials for treating diabetic cardiomyopathy, as well as is in phase I clinical trials to treat diabetic peripheral neuropathy; and AT-003 that is in phase I clinical trial for the treatment diabetic retinopathy. The company's preclinical stage products include AT-104 for the treatment of orphan hematological oncology. Applied Therapeutics, Inc. was founded in 2016 and is headquartered in New York, New York.
| Top 10 Open Interest For Feb 20 Expiration | Top 5 High Yield | |||||
|---|---|---|---|---|---|---|
| 1. | NVDA covered calls | 6. | SPY covered calls | 1. | OCUL covered calls | |
| 2. | GLD covered calls | 7. | QQQ covered calls | 2. | AXTI covered calls | |
| 3. | SLV covered calls | 8. | TLT covered calls | 3. | OPEN covered calls | |
| 4. | KWEB covered calls | 9. | INTC covered calls | 4. | CRWV covered calls | |
| 5. | IBIT covered calls | 10. | EWZ covered calls | 5. | IBRX covered calls | |
Want more examples? APLS Covered Calls | APO Covered Calls
